By Beehive Blends announces new product launches featuring its patent-pending EOCO time-release technology, the Ground Control Capsules, setting a new standard in accessible and effective cannabinoid therapy.
United States, 9th Dec 2024 – Beehive Blends, a pioneering leader in plant-based wellness, has unveiled its latest advancements in cannabinoid therapy with the introduction of new product offerings powered by its patent-pending Essence of Cannabis Oil (EOCO) technology.
EOCO technology, a time-release delivery system, provides patients with sustained therapeutic benefits, ensuring consistent and reliable relief. This innovation has already earned recognition, with awards such as “Most Innovative New Medicine” and “Best Overall Edible,” reinforcing Beehive Blends’ role as a trailblazer in natural medicine.
The EOCO system addresses a crucial gap in cannabinoid therapy by providing a controlled release of cannabinoids, enhancing efficacy while minimizing the unpredictability often associated with traditional products. This scientific approach demonstrates Beehive Blends’ commitment to pushing the boundaries of plant-based medicine.
Exciting New Product Launches
Beehive Blends’ announcement includes the debut of three highly anticipated full spectrum edible products, each reflecting the company’s dedication to combining therapeutic efficacy with patient-centric innovation:
- Hemp Hash Rosin Caramels: These premium caramels deliver the therapeutic benefits of hash rosin in a delicious and convenient format, appealing to both wellness-focused individuals and those seeking a luxurious edible experience.
- Full-Spectrum FECO Gummies: Crafted with full-extract cannabis oil, these gummies offer a potent, full-spectrum approach to cannabinoid therapy. Designed for maximum effectiveness, they provide a balance of taste and wellness.
- Hemp Hash Rosin Chocolate Bars: By combining gourmet chocolate with the therapeutic properties of hash rosin, these bars redefine the intersection of indulgence and wellness.
Each product utilizes either a full spectrum hemp derived FECO (full extracted cannabinoid oil) or Hash Rosin. to ensure optimal absorption and consistent therapeutic effects, setting a new benchmark for cannabinoid-based solutions.
Accessibility and Advocacy: The Major Tom Sponsorship Program
As part of its mission to make cutting-edge therapy accessible to all, Beehive Blends has introduced the Major Tom Sponsorship Program. This initiative underscores the company’s commitment to affordability, offering patients a month’s supply of Ground Control Capsules for just $0.50 a day.
The capsules, powered by EOCO technology, provide a time-release formulation that delivers therapeutic relief throughout the day. This program not only addresses financial barriers to accessing cannabinoid therapy but also aligns with the company’s guiding principle: helping people should be the priority, with profits as a secondary outcome.
“This program is a reflection of our values,” said Joshua Edward Graston, Director of Scientific Operations at Beehive Blends. “By putting people first, we aim to set a standard for what compassionate, innovative care should look like in the wellness industry. Profits are a side effect of genuinely helping people.”
Collaborating for Impact: Stoner Gump Partnership
Beehive Blends has also partnered with influencer Stoner Gump, a prominent advocate for plant-based wellness. This collaboration is designed to amplify awareness of the company’s innovative approaches, reaching diverse audiences and fostering a broader understanding of cannabinoid therapy.
Stoner Gump’s involvement underscores the shared mission of destigmatizing plant-based medicine and educating the public about the transformative potential of natural therapies.
Redefining the Cannabinoid Therapy Landscape
Beehive Blends is more than a wellness company—it’s a movement redefining how cannabinoid therapy can empower patients and enhance lives. By integrating scientific advancements with a deep respect for nature’s wisdom, the company is pioneering solutions that are sustainable, effective, and inclusive.
“Our mission is to bridge the gap between science and nature,” said Company Founder Chris Miles. “We are not only creating products but also crafting pathways for better health and wellness for people across the world.”
Through its innovative EOCO technology and groundbreaking product lineup, Beehive Blends continues to lead the charge in evolving cannabinoid-based medicine. With a focus on accessibility, sustainability, and scientific precision, the company is reshaping what’s possible in the realm of natural health solutions.
About Beehive Blends
Beehive Blends is at the forefront of plant-based wellness, specializing in the therapeutic potential of minor cannabinoids. Founded with a vision to redefine cannabinoid therapy, the company combines scientific innovation with nature’s wisdom to deliver groundbreaking solutions all while respecting the traditional and cultural history of the plant. Serving patients across the United States and Great Britain, Beehive Blends remains committed to quality, sustainability, and accessibility.
Director of Scientific Operations
Phone: +1 (539) 240-0698
Website: BeehiveBlends.com
Facebook
Media Contact
Organization: Beehive Blends
Contact Person: Joshua Edward Graston
Website: https://www.beehiveblends.com
Email: Send Email
Country:United States
Release id:20964
Information contained on this page is provided by an independent third-party content provider. Binary News Network and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]
Comments